Potassium phosphate

Application 2,3-Butanedione monoxime has been used: in single-molecule myosin V motility assays as an anesthetic in the approach of imaging transgenic animals to reduce rigor tension in muscle fibres as a media component for mice cardiomyocytes

Application 2,3-Butanedione monoxime has been used: in single-molecule myosin V motility assays as an anesthetic in the approach of imaging transgenic animals to reduce rigor tension in muscle fibres as a media component for mice cardiomyocytes

Application 2,3-Butanedione monoxime has been used: in single-molecule myosin V motility assays as an anesthetic in the approach of imaging transgenic animals to reduce rigor tension in muscle fibres as a media component for mice cardiomyocytes

Application 2,3-Butanedione monoxime has been used: in single-molecule myosin V motility assays as an anesthetic in the approach of imaging transgenic animals to reduce rigor tension in muscle fibres as a media component for mice cardiomyocytes

The Moltox potassium phosphate buffer is mainly used in research facilities and chemical laboratories to conduct wide range of experiments. It is available in sturdy bottle that endures heavy and rigorous usage.

General description Chromogenic substrate for the determination of acid and alkaline phosphatases. The reaction produces a soluble end product that is yellow in color.

General description Chromogenic substrate for the determination of acid and alkaline phosphatases. The reaction produces a soluble end product that is yellow in color.

An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1) also inhibits PKA and Cdk2 with IC₅₀ values of 16 and 46 nM, respectively reduces phosphorylation of Akt downstream targets in cells and slows proliferation of tumor

An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1) also inhibits PKA and Cdk2 with IC₅₀ values of 16 and 46 nM, respectively reduces phosphorylation of Akt downstream targets in cells and slows proliferation of tumor

An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1) also inhibits PKA and Cdk2 with IC₅₀ values of 16 and 46 nM, respectively reduces phosphorylation of Akt downstream targets in cells and slows proliferation of tumor

An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1) also inhibits PKA and Cdk2 with IC₅₀ values of 16 and 46 nM, respectively reduces phosphorylation of Akt downstream targets in cells and slows proliferation of tumor

An intermediate in the interconversion of glucose and galactose.